Browse 472 Federal Consumer Protection Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Consumer Protection grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 4th, 2023 |
Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional |
Food and Drug Administration |
April 22nd, 2023 |
PDS - Annual Program Statement 2023 |
US Mission to India |
April 30th, 2023 |
Pool Safely Grant Program (psgp) |
Consumer Product Safety Commission |
April 14th, 2023 |
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
March 29th, 2023 |
Pediatric Device Consortia Grants Program (P50) Clinical Trials Optional |
Food and Drug Administration |
April 14th, 2023 |
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
March 7th, 2023 |
Cooperative Agreement to Support the Food and Agriculture Organization (FAO) (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
April 26th, 2023 |
Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional |
Food and Drug Administration |
January 31st, 2023 |
Academy of Women Entrepreneurs Program in Consular District Hyderabad |
US Mission to India |
February 14th, 2023 |
Assuring Radiation Protection (U18) Clinical Trial Not Allowed |
Food and Drug Administration |
January 17th, 2023 |
Building Research Capacity in Global Tobacco Product Regulation Program (U18) Clinical Trials Not Allowed |
Food and Drug Administration |
March 22nd, 2023 |
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
April 3rd, 2023 |
In Vivo Regional Deposition Measurements for Supporting Model Validation (U01) Clinical Trial Required |
Food and Drug Administration |
March 21st, 2023 |
Development and Validation of a Multi-functional, Multi-purpose Quantitative Tool for Dermal Physiologically-Based Pharmacokinetic (PBPK) Modeling (U01) Clinical Trial Optional |
Food and Drug Administration |
February 28th, 2023 |
Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
March 15th, 2023 |
Evaluation of oral modified release drug tablet to support the approval of additional strengths |
Food and Drug Administration |
February 15th, 2023 |
Designing and performing a virtual bioequivalence trial for physiologically-based pharmacokinetic and other mechanism-based models |
Food and Drug Administration |
February 22nd, 2023 |
Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional |
Food and Drug Administration |
February 27th, 2023 |
Novel approaches to support therapeutic development in ultra-rare cancers |
Food and Drug Administration |
March 7th, 2023 |
Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed. |
Food and Drug Administration |
|
November 4th, 2022 |
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required |
Food and Drug Administration |
May 22nd, 2023 |
Annual Program Statement - Public Diplomacy Small Grants |
US Mission to India |
August 3rd, 2022 |
Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Obstetrics Pain |
Food and Drug Administration |
August 3rd, 2022 |
Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Prescribing of Benzodiazepines |
Food and Drug Administration |
December 22nd, 2022 |
Centers of Excellence in Regulatory Science and Innovation (CERSI) |
Food and Drug Administration |
June 6th, 2022 |
Funding Opportunity Title Innovation Award: Minority Health and Health Equity (U01) Clinical Trials Optional |
Food and Drug Administration |
July 22nd, 2022 |
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Optional |
Food and Drug Administration |
June 20th, 2022 |
Pool Safely Grant Program (psgp) |
Consumer Product Safety Commission |
April 29th, 2022 |
Renewal - Native American Tribes Outreach, Education, and Training to Enhance Food Safety and FSMA Compliance (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
April 29th, 2022 |
Renewal- Local Food Producer Outreach, Education, and Training to Enhance Food Safety and FDA Food Safety Modernization Act (FSMA) Compliance (U01) Clinical Trail Not Allowed |
Food and Drug Administration |
May 9th, 2022 |
Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional |
Food and Drug Administration |
April 15th, 2022 |
FY2022 U.S. Embassy Tokyo: Re-energize IVLP alumni |
US Mission to Japan |
April 15th, 2022 |
FY2022 U.S. Embassy Tokyo: U.S. Exchange Program on Securing Japan's Research Space |
US Mission to Japan |
April 22nd, 2022 |
Retail Food Safety Regulatory Association Collaboration (U18) [Clinical Trial Not Allowed] |
Food and Drug Administration |
April 4th, 2022 |
Revision Applications - Manufactured Food Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed] |
Food and Drug Administration |
April 4th, 2022 |
Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18) [Clinical Trials Not Allowed] |
Food and Drug Administration |
April 4th, 2022 |
Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
February 22nd, 2022 |
Building an Integrated Information Technology Infrastructure for State Regulatory Programs (U2F) [Clinical Trial Not Allowed] |
Food and Drug Administration |
February 28th, 2022 |
Conformance with the Egg Regulatory Program Standards (U2F) [Clinical Trial Not Allowed] |
Food and Drug Administration |
March 31st, 2022 |
Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed) |
Food and Drug Administration |